St. Jude Results Reflect Troubled 2012, But Atrial Fib Sales Shine

Devices & Diagnostics Letter
St. Jude Medical expects less than half of its 2013 income to come from cardiac rhythm management (CRM) sales, due to an ongoing global slowdown in the market for cardiac devices, CEO Dan Starks said in a Tuesday earnings call.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00